Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.
Nitinol-based Stent Market contains market size and forecasts of Nitinol-based Stent in global, including the following market information:
- Global Nitinol-based Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Nitinol-based Stent Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Nitinol-based Stent companies in 2021 (%)
The global Nitinol-based Stent market was valued at 20800 million in 2021 and is projected to reach US$ 39430 million by 2028, at a CAGR of 9.6% during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Bare-metal Stent (BMS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Nitinol-based Stent include Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- surveyed the Nitinol-based Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nitinol-based Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nitinol-based Stent Market Segment Percentages, by Type, 2021 (%)
- Bare-metal Stent (BMS)
- Drug-eluting Stent (DES)
Global Nitinol-based Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nitinol-based Stent Market Segment Percentages, by Application, 2021 (%)
Global Nitinol-based Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nitinol-based Stent Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nitinol-based Stent revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Nitinol-based Stent revenues share in global market, 2021 (%)
- Key companies Nitinol-based Stent sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Nitinol-based Stent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medtronic
- Edwards Lifesciences
- Abbott
- Boston Scientific
- TERUMO
- C. R. Bard
- Cordis
- Cook Medical
- B. Braun
- Biotronik
- Stryker
- JOTEC
- MicroPort
- Acandis
- ELLA-CS
Industry Market Size
